Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study.
about
Advances in treatment of pediatric brain tumorsPhase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors.A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.The impact of coexisting genetic mutations on murine optic glioma biology.Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions.CNS Tumors in Neurofibromatosis.Whole tumor RNA-sequencing and deconvolution reveal a clinically-prognostic PTEN/PI3K-regulated glioma transcriptional signature.Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.Pediatric Low-Grade Gliomas: Next Biologically Driven Steps.
P2860
Q33237311-B5B64A8B-4E28-4105-A2CD-D28AC63867D7Q33780411-88360D92-242A-466D-BA3C-AD8A0ECD44A7Q35133435-E2292E64-DB7F-4128-9B67-3759253FDA2FQ35670831-2D48476B-4363-4982-A59A-334A12D72176Q35788566-2C00032B-521A-49D7-B2B8-EB0B0853BC0EQ35788976-A590EC49-71A5-430D-871A-AAFF4507AFA0Q36261364-04C02CB0-A75D-4320-B444-65F4DA156C07Q36771546-D8F326B1-50A3-4959-8C4A-E5725490032DQ37740616-01AFAFD4-6B9F-4A4E-BD2B-DA9E2938E3A2Q38713914-115BD1A5-B3A3-4C27-961C-6FCC686D6E22Q41592763-59052B8D-CDE7-4B04-9BAB-25DCCE6BE5F0Q41820623-FF6EA569-1668-4598-92BA-9FBA991DF301Q46667195-FC0DA3A7-8383-4660-B9F3-EF720FBFB791
P2860
Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Carboplatin is effective thera ...... Oncology Group phase II study.
@ast
Carboplatin is effective thera ...... Oncology Group phase II study.
@en
Carboplatin is effective thera ...... Oncology Group phase II study.
@nl
type
label
Carboplatin is effective thera ...... Oncology Group phase II study.
@ast
Carboplatin is effective thera ...... Oncology Group phase II study.
@en
Carboplatin is effective thera ...... Oncology Group phase II study.
@nl
prefLabel
Carboplatin is effective thera ...... Oncology Group phase II study.
@ast
Carboplatin is effective thera ...... Oncology Group phase II study.
@en
Carboplatin is effective thera ...... Oncology Group phase II study.
@nl
P2093
P1433
P1476
Carboplatin is effective thera ...... Oncology Group phase II study.
@en
P2093
D H Mahoney
J L Kepner
J W Langston
P K Duffner
P304
P356
10.1215/S1522851700000223
P577
2000-10-01T00:00:00Z